N-Methyl-N-ethyltryptamine

N-Methyl-N-ethyltryptamine
Names
	Preferred IUPAC name N-Ethyl-2-(1H-indol-3-yl)-N-methylethan-1-amine
Identifiers
CAS Number	5599-69-9 ;
3D model (JSmol)	Interactive image;
ChemSpider	720502 ;
PubChem CID	824845;
UNII	4KX1J1D3RD ;
CompTox Dashboard (EPA)	DTXSID901024010 ;
	InChI InChI=1S/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3 Key: MYEGVMLMDWYPOA-UHFFFAOYSA-N ; InChI=1/C13H18N2/c1-3-15(2)9-8-11-10-14-13-7-5-4-6-12(11)13/h4-7,10,14H,3,8-9H2,1-2H3 Key: MYEGVMLMDWYPOA-UHFFFAOYAX;
	SMILES c1cccc2c1c(c[nH]2)CCN(CC)C;
Properties
Chemical formula	C13H18N2
Molar mass	202.295 g/mol
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

N-Methyl-N-ethyltryptamine (MET) is a psychedelic tryptamine. It is closely related to DMT and DET.^[1]^[2] The lysergamide counterpart of MET is ETH-LAD, an analogue of LSD first developed and characterized by Alexander Shulgin.

There is very little information on the human pharmacology or toxicity of MET. The freebase is believed to be active via vaporization at 15 mg.^[3]

References

^ Schifano, Fabrizio; Orsolini, Laura; Papanti, Duccio; Corkery, John (2016). "NPS: Medical Consequences Associated with Their Intake". Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences. Vol. 32. pp. 351–380. doi:10.1007/7854_2016_15. ISBN 978-3-319-52442-9. PMID 27272067.
^ Halberstadt, Adam L.; Geyer, Mark A. (2016). "Effect of Hallucinogens on Unconditioned Behavior". Behavioral Neurobiology of Psychedelic Drugs. Current Topics in Behavioral Neurosciences. Vol. 36. pp. 159–199. doi:10.1007/7854_2016_466. ISBN 978-3-662-55878-2. PMID 28224459.
^ "That's okay, you're good" MET trip report - The Vaults of Erowid

"Tryptamines i Have Known And Loved", Erowid's online version of TiHKAL, a book about Tryptamines

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.